Davangere Devanand, MD: The State of Dementia Drug Development
Devanand reviews lecanemab and the advent of blood biomarkers for dementia and Alzheimer's management at APA 2024.
Charles R. Marmar, MD: Blood Biomarkers for PTSD
Marmar explains what anticipated blood and molecular profiling of PTSD may provide psychiatrists treating patients.
John Kane, MD: Shifts in Antipsychotics for Schizophrenia
Kane explains why newer long-acting injectables and clozapine may be under-utilized still in the management of schizophrenia.
Changing Landscape of Modifiable Cardiovascular Risk Factors, with Payal Kohli, MD
Payal Kohli, MD, discusses how recent advancements have changed conversations surrounding modifiable cardiovascular risk and what it means for practitioners.
Addressing Stigma to Improve Outcomes in Alcohol-Related Liver Disease
The second segment of a special report stresses the importance of cross-specialty collaboration with hepatology and psychiatry when treating alcohol-related liver disease.
Recognizing Stigma's Impact on Care for Alcohol-Related Liver Disease
In the first segment of this HCPLive special report, experts discuss the stigma surrounding alcohol use disorder and alcohol-associated liver disease.
Air Quality Issues Due to Particle Pollution with John Balmes, MD
This segment of the latest Lungcast episode featured a discussion over the ALA’s State of the Air Report and the impacts of particle pollution.
Daniel Gaudet, MD, PhD: Contextualizing Plozasiran Data from SHASTA-2, Upcoming MUIR Data
Daniel Gaudet, MD, PhD, discusses SHASTA-2 data and what cardiologists could learn from the forthcoming 48-week MUIR trial data from EAS 2024.
Ugochi Ohuabunwa, MD: Preparing Patients for the Postdischarge Transition of Care
During this discussion, Ohuabunwa discussed additional takeaways from her ACP conference talk on postdischarge care and other tips for internal medicine physicians.
Ugochi Ohuabunwa, MD: Tips for Inpatient Geriatric Management, Frailty Assessment
This discussion with Ohuabunwa was held at the ACP conference and covered inpatient geriatrics assessment tips for internal medicine physicians.
Matthew Nudy, MD: Balancing the Benefits and Risk of Intensive Blood Pressure Control
Matthew Nudy, MD, discusses a trio of meta-analyses examining the effects of intensive blood pressure control on various targets.
Audrey Chun, MD: Recommendations on Statins, Connecting Dementia to Hearing Loss
Chun spoke in this interview segment about more recommendations for internal medicine physicians to give older adults related to aging, dementia, and statin use.
Audrey Chun, MD: Practical Recommendations to Give Older Patients for Exercise, Cognitive Health
In this interview, Chun discussed recommendations for internal medicine physicians to give older adults for slowing aging as well as evidence for statins.
Patrick Hemming, MD: Which Mental Health App is Best for Internal Medicine Patients?
This segment of Hemming’s ACP interview featured a discussion of a website used to assess digital applications for patients struggling with mental health issues.
Anne Thorndike, MD, MPH: Discussing Obesity, Physical Activity, Weight Loss Drugs
Another segment of her ACP 2024 interview featured a discussion on weight loss drugs, healthy living, and discussions with patients.
Anne Thorndike, MD, MPH: Discussing Treatment Approaches for Patients with Obesity
Thorndike discussed highlights from her ACP 2024 talk titled ‘Annals Beyond the Guidelines: How Would You Treat this Patient with Obesity?’
Bruce Leff, MD, MACP: Discussing ‘Hospital at Home’ Program, Important Takeaways
In this segment of his interview, Leff described what he hopes internal medicine physicians viewing his talk walk away realizing about Hospital at Home.
Bruce Leff, MD, MACP: Discussing the ‘Hospital at Home’ Program for Older Adults
At the ACP Internal Medicine Meeting, Leff described the outcomes and implementation of the ‘Hospital at Home’ program for elderly adults.
Patrick Hemming, MD: Depression, Anxiety Treatment by the Internal Medicine Physician
This discussion with Hemming featured the biggest takeaways from his talk titled ‘Depression and Anxiety Treatment by the Internal Medicine Physician.’
Patrick Hemming, MD: Using the Mental Health Care Model for Depression in Primary Care
This interview at ACP 2024 featured a discussion with Hemming on the Mental Health Care Model (MHCM) and addressing depression in primary care settings.
Discussing Ways to Approach Improving Obesity Care with Melanie Jay, MD
During this segment of her interview at the ACP Internal Medicine Meeting, Jay discussed improving obesity care, telehealth utilization for patients, and more.
Melanie Jay, MD: Advancing Equitable Approaches to Improve Obesity Care
This interview segment featured a discussion on Jay’s ACP Internal Medicine Meeting presentation ‘Advancing Equitable Approaches to Improve Obesity Care.’
Sharon K. Inouye, MD, MPH: Why is Delirium During Hospitalization Not Taken Seriously?
This ACP Conference interview featured a discussion with Inouye about gaps in knowledge regarding patients experiencing delirium during hospitalization.
Discussing Delirium During Hospitalization with Sharon K. Inouye, MD, MPH
In this interview at the ACP conference, Inouye discussed some of the major reasons for her presentation titled ‘Delirium During Hospitalization.’
Elna Saah, MD: Unraveling the Current Landscape in Sickle Cell Disease
Elna Saah, MD joins HCPLive to discuss the current landscape in sickle cell disease and recent advancements benefiting clinical care.
Diabetes Dialogue: STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies
In this episode, hosts discuss the STEP HFpEF DM trial and the need for fair allocation of incretin-based therapies with ongoing shortages and overwhelming demand.
Ersilia DeFilippis, MD: Need for Equity, Policy Change in Heart Failure Transplant
Ersilia DeFillipis, MD, discusses a trio of studies she presented at ACC.24 examining different financial hurdles and barriers encountered by people in need of heart transplants.
HCPLive Five at ACC 2024
Counting down the most impactful news at major medical meetings, it’s the HCPLive Five! This edition focuses on 5 updates from the American College of Cardiology 2024 (ACC.24) Annual Scientific Sessions.
Ankeet Bhatt, MD, MBA: Sacubitril/Valsartan vs ACEi/ARB in de novo HFmrEF/HFpEF
A retrospective analysis of EHR data from ACC.24 provides insight into the effects of ARNI relative to ACEi/ARB in patients with newly diagnosed heart failure and an LVEF greater than 40%.
Safia Chatur, MD: Sacubitril/Valsartan Offers Benefit in HFrEF Across New KDIGO Risk Classes
Safia Chatur, MD, discusses the results of a PARADIGM-HF analysis at ACC.24 examining the effects of ARNI use across the updated 2024 KDIGO Risk Classifications.
